AngioSoma, Inc. (SOAN) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Houston, TX, United States. The current CEO is Alex K. Blankenship.
SOAN has IPO date of 2022-01-31, listed on the Other OTC.
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
